Why Queensland?
Queensland’s network of bright minds and diverse disciplines, world-class services, trial sites, and broad patient population uniquely position Queensland to deliver clinical research excellence.
Strengths
Queensland is at the forefront of the nation’s teletrial capabilities, bringing clinical trials closer to home for patients in our regional communities and maximising patient recruitment year-round.
Value
Queensland’s clinical trials ecosystem accelerates the translation of research into improved practices and technologies, supporting startups and scaleups.
Governance
Queensland’s clinical trials processes are streamlined to enabled rapid start-up (4-6 weeks) and to ensure patient safety and easy access to our resources including our state-of-the-art facilities, clinical research sites practitioners, industry groups, researchers and study sponsors.
Sites
Queensland offers access to an ethnically diverse patient population across our cities, regional, rural, and remote areas; increasing the likelihood of meeting specific recruitment needs and accessing a large treatment-naïve population.

News updates
- CTX changed to CTA - see the trial process here.
- NHMRC National Statement 2023
- Latest revision of the ICH Guideline for conducting clinical trials- ICH E6(R3) Guideline for Good Clinical Practice.
- Queensland Health Clinical Trial Strategic Action Plan: Report card-September 2024
- A new report, Queensland Public Hospitals: Health and Medical Research Activities (2019-2024), details the state's research efforts. For more details, read the full report here: Queensland Public Hospitals Research Report